 |
 |
 |
 |
 |
 |
 |
 |
|
The strategy of ImmuneRegen BioSciences, Inc., is to increase the value of its programs through both scientifically driven development and partnerships. The company seeks pharmaceutical and/or biotechnology partners that can rapidly advance programs and thus enhance corresponding asset values to the benefit of both partners. Our partnerships with Delsite BioTechnologies, BioCure, and ULURU are collaborations of this nature.
For information regarding collaboration or licensing opportunities with ImmuneRegen BioSciences, Inc., please contact Michael Wilhelm at mwilhelm@immuneregen.com.
